List of insiders holdings for Flexion Therapeutics Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Sofinnova Partners SAS 10% Owner |
2016-02-16 13:09:26 | 1,901,491 0 |
1,901,491 | Form 13G |
2 | Versant Ventures III LLC Versant Venture Capital III L.P. Versant Side Fund III L.P. Versant Development Fund III L.P. ATWOOD BRIAN G COLELLA SAMUEL D JAFFE ROSS A MD LINK WILLIAM J PHD MILDER DONALD B ROBERTSON REBECCA B 10% Owner |
2021-01-25 17:57:58 | 1,388,683 0 |
1,388,683 | Form 13D |
3 | Novo A/S 10% Owner |
2015-09-30 12:12:07 | 1,033,131 0 |
1,033,131 | Form 13D |
4 | PFIZER INC 10% Owner |
2016-02-11 17:00:58 | 926,309 0 |
926,309 | Form 13G |
5 | Bodick Neil Chief Scientific Officer |
2020-01-07 16:28:24 | 100,153 389,683 |
489,836 | Form 4 |
6 | 5AM Ventures II LP 5AM CO-INVESTORS II LP 10% Owner |
2016-02-11 18:06:06 | 461,563 0 |
461,563 | Form 13G |
7 | LUBASH BARBARA N Bolzon Bradley J PhD Warden Charles M Praeger Robin L. 10% Owner |
2016-06-10 21:40:32 | 0 409,422 |
409,422 | Form 4 |
8 | Arkowitz David Chief Financial Officer |
2021-05-12 17:06:20 | 220,719 0 |
220,719 | Form 4 |
9 | Fratamico Arthur Chief Business Officer |
2014-02-11 20:18:19 | 121,401 0 |
121,401 | Form 3 |
10 | Mahatme Sandesh Director |
2020-06-12 16:17:55 | 11,500 0 |
11,500 | Form 4 |
11 | Deniz Yamo Chief Medical Officer |
2017-09-15 17:12:15 | 9,030 0 |
9,030 | Form 4 |
12 | Tordjman Rafael Director 10% Owner |
2014-03-04 18:45:16 | 9,000 0 |
9,000 | Form 4 |
13 | Schwab Andrew J. Director 10% Owner |
2014-03-04 18:44:15 | 9,000 0 |
9,000 | Form 4 |
14 | KELLEY SCOTT Chief Medical Officer |
2021-03-15 18:05:12 | 5,334 0 |
5,334 | Form 3/A |
15 | Canute Scott A Director |
2021-11-19 10:10:52 | 0 0 |
0 | Form 4 |
16 | Koppikar Utpal Director |
2021-11-19 10:13:44 | 0 0 |
0 | Form 4 |
17 | Kwo Elizabeth Director |
2021-11-19 10:14:55 | 0 0 |
0 | Form 4 |
18 | COLELLA SAMUEL D Director |
2021-11-19 10:12:26 | 0 0 |
0 | Form 4 |
19 | Andrews William T. Chief Medical Officer |
2021-11-19 09:58:58 | 0 0 |
0 | Form 4 |
20 | Lukatch Heath Director |
2021-11-19 10:16:24 | 0 0 |
0 | Form 4 |
21 | MERRIFIELD C ANN Director |
2021-11-19 10:17:43 | 0 0 |
0 | Form 4 |
22 | MILINAZZO ALAN Director |
2021-11-19 10:19:17 | 0 0 |
0 | Form 4 |
23 | Stejbach Mark Director |
2021-11-19 10:20:34 | 0 0 |
0 | Form 4 |
24 | Newtyn Management LLC 10% Owner |
2021-11-23 19:00:12 | 0 0 |
0 | Form 4 |
25 | MAHAFFY PATRICK J Director |
2021-11-19 10:09:28 | 0 0 |
0 | Form 4 |
26 | Levine Mark S. General Counsel |
2021-11-19 10:08:00 | 0 0 |
0 | Form 4 |
27 | Muzikant Adam Chief Business Officer |
2021-11-19 10:06:44 | 0 0 |
0 | Form 4 |
28 | Wentworth Kerry Chief Regulatory Officer |
2021-11-19 10:04:54 | 0 0 |
0 | Form 4 |
29 | Layman Melissa Chief Commercial Officer |
2021-11-19 10:03:15 | 0 0 |
0 | Form 4 |
30 | Willwerth Christina Chief Strategy Officer |
2021-11-19 10:01:34 | 0 0 |
0 | Form 4 |
31 | DRISCOLL FREDERICK W Chief Financial Officer |
2021-11-19 10:00:04 | 0 0 |
0 | Form 4 |
32 | Clayman Michael D. President and CEO |
2021-11-19 09:56:54 | 0 0 |
0 | Form 4 |
33 | Jones Elaine V Director |
2014-02-11 20:19:47 | 0 0 |
0 | Form 3 |